Publications

Publications 1151 - 1175 de 33557
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma
F. Selle; E. Sevin; I. Ray-Coquard; V. Mari; D. Berton-Rigaud; L. Favier; M. Fabbro; A. Lesoin; A. Lortholary; E. Pujade-Lauraine
2014
10.1093/annonc/mdu392
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R. Galot; C. Le Tourneau; E. Saada-Bouzid; A. Daste; C. Even; P.R. Debruyne; S. Henry; S. Zanetta; A. Rutten; L.F. Licitra; J.L. Canon; M.C. Kaminsky-Forrett; P. Specenier; S. Rottey; L. Dirix; T. Raveloarivahy; F. Lefevre; M.B.M. Vanlancker; A.S. Govaerts; J.P. Machiels
2019
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
E. Van Den Neste; M. Andre; T. Gastinne; A. Stamatoullas; C. Haioun; A. Belhabri; O. Reman; O. Casasnovas; H. Ghesquieres; G. Verhoef; M.J. Claessen; H.A. Poirel; M.C. Copin; R. Dubois; P. Vandenberghe; I.A. Stoian; A.S. Cottereau; S. Bailly; L. Knoops; F. Morschhauser
2018
10.3324/haematol.2017.180554
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi; T. Grellety; O. Tredan; M. Saghatchian; F. Dalenc; A. Mailliez; T. L'Haridon; P. Cottu; S. Abadie-Lacourtoisie; B. You; M. Mousseau; J. Dauba; F. Del Piano; I. Desmoulins; F. Coussy; N. Madranges; J. Grenier; F.C. Bidard; C. Proudhon; G. MacGrogan; C. Orsini; M. Pulido; A. Goncalves
2016
10.1093/annonc/mdw067
A phase II trial of sorafenib (SO) in advanced chordoma patients (pt)
E. Amela; E. Bompas; A. Le Cesne; E. Tresch; A. Italiano; S. Piperno-Neumann; O. Collard; D. Vansteene; J. Domont; E. Saada; N. Isambert; S. Salas; C. Chevreau; F. Bertucci; S.Clisant Delaine; J.Y. Blay; N. Penel
2015
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
B. Coiffier; C. Thieblemont; S. de Guibert; J. Dupuis; V. Ribrag; R. Bouabdallah; F. Morschhauser; R. Navarro; S. Le Gouill; C. Haioun; R. Houot; O. Casasnovas; H. Holte; T. Lamy; F. Broussais; S. Payrard; L. Hatteville; H. Tilly
2016
10.1111/bjh.13992
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial
B. Bui-Nguyen; J.E. Butrynski; N. Penel; J.Y. Blay; N. Isambert; M. Milhem; J.M. Kerst; A.K.L. Reyners; S. Litiere; S. Marreaud; F. Collin; W.T.A. van der Graaf; E.O.R.T.C. STBSG; SARC
2015
10.1016/j.ejca.2015.03.023
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
K. Fizazi; A. Maillard; N. Penel; G. Baciarello; D. Allouache; G. Daugaard; A. van de Wouw; G. Soler; E. Vauleon; L. Chaigneau; R. Janssen; L. Gaspa; M. Barrera; C. Balana; D. Tosi; B. Chauffert; C.A. Schnabel; G. Martineau; S. Culine; I. Borget
2019
10.1093/annonc/mdz394
A Phase Transition for Large Values of Bifurcating Autoregressive Models
V. Bansaye; V.Bitseki Penda
2021
10.1007/s10959-020-01033-w
A phase-based framework for optical flow estimation on omnidirectional images
B. Alibouch; A. Radgui; C. Demonceaux; M. Rziza; D. Aboutajdine
2016
10.1007/s11760-014-0739-z
A phase-by-phase upstream scheme that converges to the vanishing capillarity solution for countercurrent two-phase flow in two-rock media
B. Andreianov; C. Cances
2014
10.1007/s10596-014-9403-5
A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers
A. Ferrari; A.S. Sertier; A. Vincent-Salomon; X. Pivot; I. Pauporte; P. Saintigny; D. Birnbaum; A. Viari
2016
10.1080/23723556.2016.1232186
A PHM System Approach: Application to a Simplified Aircraft Bleed System
J. Maitre; J.Sen Gupta; K. Medjaher; N. Zerhouni
2016
A physical-based constitutive model for surface integrity prediction in machining of OFHC copper
L.A. Denguir; J.C. Outeiro; G. Fromentin; V. Vignal; R. Besnard
2017
10.1016/j.jmatprotec.2017.05.009
A physics-based approach to relate grinding process parameters to tribological behavior of ground surfaces
O. Fergani; M. Yousfi; Z. Ding; T. Welo; S.Y. Liang
2017
10.1007/s00170-017-0111-x
A piezo-shunted kirigami auxetic lattice for adaptive elastic wave filtering
M. Ouisse; M. Collet; F. Scarpa
2016
10.1088/0964-1726/25/11/115016
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot; O. Chazouilleres; A. Rousseau; A. Le Gruyer; F. Habersetzer; P. Mathurin; O. Goria; P. Potier; A. Minello; C. Silvain; A. Abergel; M. Debette-Gratien; D. Larrey; O. Roux; J.P. Bronowicki; J. Boursier; V. De Ledinghen; A. Heurgue-Berlot; E. Nguyen-Khac; F. Zoulim; I. Ollivier-Hourmand; J.P. Zarski; G. Nkontchou; S. Lemoinne; L. Humbert; D. Rainteau; G. Lefevre; L. de Chaisemartin; S. Chollet-Martin; F. Gaouar; F.H. Admane; T. Simon; R. Poupon
2018
10.1056/NEJMoa1714519
A Plant Extract Acts Both as a Resistance Inducer and an Oomycide Against Grapevine Downy Mildew
Y. Krzyzaniak; S. Trouvelot; J. Negrel; S. Cluzet; J. Valls; T. Richard; A. Bougaud; L. Jacquens; A. Klinguer; A. Chiltz; M. Adrian; M.C. Heloir
2018
10.3389/fpls.2018.01085
A plant perspective on nitrogen cycling in the rhizosphere
D. Moreau; R.D. Bardgett; R.D. Finlay; D.L. Jones; L. Philippot
2019
10.1111/1365-2435.13303
A plant-functional-type approach tailored for stakeholders involved in field studies to predict forage services and plant biodiversity provided by grasslands
M. Duru; C. Jouany; J.P. Theau; S. Granger; P. Cruz
2015
10.1111/gfs.12129
A plea for the pathogenic role of immune complexes in severe Covid-19
D.A. Vuitton; L. Vuitton; E. Seilles; P. Galanaud
2020
10.1016/j.clim.2020.108493
A plea to remove the word ``condyle'' from the international anatomical nomenclature
O. Trost; F. Crampon; G. Prum; P. Trouilloud; F. Duparc
2020
10.1007/s00276-019-02296-7
A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial
Y. Goueffic; A. Sauguet; P. Desgranges; P. Feugier; E. Rosset; E. Ducasse; A. Cardon; L.Salomon Du Mont; J.Marc Pernes; P. Commeau; P. Lermusiaux; B. Leclere; B. Guyomarch; C. Hoffmann; B. Maurel
2019
10.1016/j.jacc.2019.08.097
A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions The BATTLE Trial
Y. Goueffic; A. Sauguet; P. Desgranges; P. Feugier; E. Rosset; E. Ducasse; A. Kaladji; L.Salomon Du Mont; J.Marc Pernes; P. Commeau; P. Lermusiaux; B. Leclere; B. Guyomarc'h; C.T. Hoffmann; B. Maurel
2020
10.1016/j.jcin.2019.12.028
A polymorphism in the T(H)2 locus control region is associated with changes in DNA methylation and gene expression
M. Schieck; V. Sharma; S. Michel; A.A. Toncheva; L. Worth; D.P. Potaczek; J. Genuneit; A. Kretschmer; M. Depner; J.C. Dalphin; J. Riedler; R. Frei; J. Pekkanen; J. Tost; M. Kabesch
2014
10.1111/all.12450

Pages